BRCA1 and ovarian carcinoma: The BRCA1 mutated ovarian cell line UWB1.289 appeared to be particularly more sensitive to the cytostatic and cytocidal effects of the tested alkylating agents than the other ovarian cancer cell lines tested in consistence to its BRCAness phenotype (t-test, p < 0.001).